Long-Term Outcomes of Primary Cardiac Lymphoma
Ibrahim Sultan, Edgar Aranda‐Michel, Andreas Habertheuer, Arman Kilic, George J. Arnaoutakis, Valentino Bianco, Olugbenga T. Okusanya
Abstract
rimary cardiac lymphoma (PCL) is a rare disease with an incidence of 1% of primary cardiac malignancies and 0.5% of all extranodal lymphomas. hemotherapy continues to be the primary treatment in PCL, but there have been reports of other treatment strategies including radiation, immunotherapy, and surgery. Unfortunately, there is a paucity of data on PCL. This study aimed to address this lack of data by leveraging a contemporary national database.
Topics & Concepts
MedicineCardiothoracic surgeryCardiac surgeryVascular surgeryGeneral surgerySurgeryCardiac tumors and thrombiLymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment